Eisai
4523.T
#2139
Rank
C$12.70 B
Marketcap
C$45.02
Share price
3.83%
Change (1 day)
12.38%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): C$2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.22. In 2022 the company made an earnings per share (EPS) of C$2.26 a decrease over its 2021 EPS that were of C$10.04.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$2.9530.52%
2022C$2.26-77.48%
2021C$10.04-41.88%
2020C$17.27-0.94%
2019C$17.4452.59%
2018C$11.43124.17%
2017C$5.10-49.42%
2016C$10.0837.08%
2015C$7.35-11.75%
2014C$8.33-3.23%
2013C$8.61-18.56%
2012C$10.57-15.51%
2011C$12.51-3.75%
2010C$13.00-1.36%
2009C$13.18